Developed pain; numbness; tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Jan2022 (Lot number: EL3249) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Rheumatoid Arthritis" (unspecified if ongoing); "celiac disease" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID]; CYMBALTA; LEXAPRO; LIVALO; OMEPRAZOLE. Past drug history included: Bactria, reaction(s): "known allergies: Bactria", notes: known allergies: Bactria, Niacin, Lipitor, Crestor; Niacin, reaction(s): "known allergies: Niacin", notes: known allergies: Bactria, Niacin, Lipitor, Crestor; Lipitor, reaction(s): "known allergies: Lipitor", notes: known allergies: Bactria, Niacin, Lipitor, Crestor; Crestor, reaction(s): "known allergies: Crestor", notes: known allergies: Bactria, Niacin, Lipitor, Crestor. Vaccination history included: Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer , prev dose brand unknown: False, prev dose lot number: EIV5318, prev dose lot unknown: False, prev dose administration date: 01Feb2021 prev dose dose number: 2), administration date: 01Feb2021, when the patient was 53 years old, for Covid-19 immunization, reaction(s): "Developed pain, numbness, tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022", "Developed pain, numbness, tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022", "Developed pain, numbness, tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022"; Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer , prev dose brand unknown: False, prev dose lot number: FJ1611, prev dose lot unknown: False, prev dose administration date: 21Jan2022 prev dose dose number: 1, prev_dose_vaccine_location=Left, arm}]), for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 27Jan2022, outcome "unknown", described as "Developed pain"; HYPOAESTHESIA (non-serious) with onset 27Jan2022, outcome "unknown", described as "numbness"; PARAESTHESIA (non-serious) with onset 27Jan2022, outcome "unknown", described as "tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Developed pain, numbness, tingling in my left foot which spread to left leg. This resolved after about 4 months but recently started up again with last booster shot 27Jan2022.   No follow-up attempts are possible. No further information is expected.